Sign up for our Oncology Central weekly news round-up

World Cancer Day: closing the care gap

World Cancer Day

To mark World Cancer Day (February 4th) Oncology Central has compiled resources from across our site and our affiliated journals in an effort to make cancer research more accessible, to help close the care gap that exists in oncology.

Patient centricity in healthcare has never been more important as patients are now striving to become more empowered to undertake shared decision in order to take ownership of their care.  In addition, there is no doubting the impact that the COVID-19 pandemic has had on altering the timeline for cancer research. In the content pieces below we explore race and ethnicity representation, diversity and inclusion as well as patient engagement tools.

Patient perspective articles

The Patient Perspective on…the aftermath of treatment
The Patient Perspective on lifestyle and cancer treatment
What do cancer patients want answered about COVID-19?
The patient perspective on… tumor mutation burden
The Patient Perspective on… immunotherapy advancements
Pharma, President, Patients: the cancer cost conundrum
An oncologist’s perspective of COVID-19: “I wish I could hug you”

Journal articles and multimedia

race and representation in clinical trials
Plain Language Summary: race and ethnicity representation in Phase I clinical trials
A call to action: antiracist patient engagement in adolescent and young adult oncology research and advocacy
Coffee Chat: mental health in the oncology clinic
gender equality in STEM
Gender equality in STEM – survey infographic
future oncology care
The future of oncology care requires integration of patient engagement and equity into practice
A call to action: antiracist patient engagement in adolescent and young adult oncology research and advocacy

Plain Language Summaries

Plain language summary of the GARNET trial: clinical activity and safety of dostarlimab for recurrent or advanced dMMR endometrial cancer patients
Plain language summary of the DESTINY-Breast01 study
Plain language summary of the final results from the DESTINY-Breast01 study
plain language summary giotag
Plain language summary of the final results from the GioTag study
tumor-cells-metastasis
A plain language summary of the ENLIVEN study: pexidartinib for tenosynovial giant cell tumor
cancer cell
A plain language summary of the ASCENT study: Sacituzumab Govitecan for metastatic triple-negative breast cancer
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for untreated non-small cell lung cancer
race and representation in clinical trials
Plain Language Summary: race and ethnicity representation in Phase I clinical trials
Here, we summarize the initial results from the ADAURA clinical study looking at treatment with osimertinib in patients with a specific type of non-small cell lung cancer
Plain Language Summary of the ADAURA study: osimertinib after surgery for EGFR-mutated NSCLC
Ripretinib for advanced gastrointestinal stromal tumor: Plain language summary of the INVICTUS study
Plain Language Summary of the INVICTUS study: ripretinib for advanced gastrointestinal stromal tumor
Comparing EGFR tyrosine kinase inhibitor treatments in EGFR-mutated non-small cell lung cancer across Asian and non-Asian patients: a plain language summary
Comparing EGFR tyrosine kinase inhibitor treatments in EGFR-mutated NSCLC across Asian and non-Asian patients: a plain language summary
Plain Language Summaries are a useful tool for sharing complex information like clinical trial results, particularly with patients and their support network
Top 5 Plain Language Summaries of clinical trial results

News stories

fair inclusion score
‘Fair inclusion score’ ranks pharma companies on their clinical trial diversity
patient activation
“Patient activation” – a novel approach to create equitable interactions between patients and doctors?
DRIVE guidelines
Representation matters: DRIVE guidelines aim to promote diversity in cancer clinical trials
POSITIVE trial
Breast cancer should not be a reason to postpone pregnancy, POSITIVE trial indicates
One in five cancer patients experience PTSD after a diagnosis, study suggests